Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Net margin is calculated as Net Income divided by its Revenue. OrganoClick AB's Net Income for the
three
months ended in Mar. 2026 was kr-1.66 Mil. OrganoClick AB's Revenue for the
three
months ended in Mar. 2026 was kr27.37 Mil. Therefore, OrganoClick AB's net margin for the quarter that ended in Mar. 2026 was -6.08%.
The historical rank and industry rank for OrganoClick AB's Net Margin % or its related term are showing as below:
OSTO:ORGC'
s Net Margin % Range Over the Past 10 Years
Min: -75.19 Med: -27.76 Max: -10.81
Current: -35.17
OSTO:ORGC's Net Margin % is ranked worse than 94.11% of 1579
companies
in the Chemicals industry
Industry Median: 3.92
vs OSTO:ORGC: -35.17
OrganoClick AB (OSTO:ORGC) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
OrganoClick AB Net Margin % Related Terms
OrganoClick AB Net Margin % Historical Data
* Premium members only.
The historical data trend for OrganoClick AB's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ORGC vs LIN, SHW, ECL: Net Margin % Comparison
For the Specialty Chemicals subindustry, OrganoClick AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrganoClick AB Net Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, OrganoClick AB's Net Margin % distribution charts can be found below:
* The bar in red indicates where OrganoClick AB's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrganoClick AB (OSTO:ORGC) has a Net Margin % of -6.08% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on OrganoClick AB and its competitors. According to the industry distribution chart, OrganoClick AB ranks #1486 out of 1579 companies in the Chemicals industry, placing it in the top 94.1%.
Is OrganoClick AB's Net Margin % too high?
OrganoClick AB's current Net Margin % is -6.08%. Based on the distribution chart, OrganoClick AB ranks #1486 out of 1579 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, OrganoClick AB has a GF Score™ of 25/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does OrganoClick AB's Net Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, OrganoClick AB ranks #1486 out of 1579 companies for Net Margin %. This places OrganoClick AB in the lower half of its industry. The industry median Net Margin % is 3.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Chemicals company?
The median Net Margin % among Chemicals companies is 3.92, based on 1,579 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on OrganoClick AB and its competitors. For the Chemicals industry, the median Net Margin % is 3.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OrganoClick AB's current Net Margin % is -6.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrganoClick AB stock overvalued right now?
Based on GuruFocus' analysis, OrganoClick AB (OSTO:ORGC) is currently considered Possible Value Trap. The stock's GF Value™ is kr1.99, compared to a current price of kr0.42 — trading 78.8% below its estimated fair value. The current Net Margin % is -6.08%. OrganoClick AB's overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For OrganoClick AB (OSTO:ORGC), the current Net Margin % is -6.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OrganoClick AB (OSTO:ORGC) Overvalued in 2026?
Based on GuruFocus' analysis, OrganoClick AB stock appears to be undervalued.
The current stock price of kr0.42 is trading 78.8% below its estimated GF Value™ of kr1.99.
GuruFocus considers OrganoClick AB to be Possible Value Trap.
Key valuation signals for OSTO:ORGC:
Net Margin %: -6.08%
GF Value™: kr1.99 vs. price of kr0.42 (78.8% below fair value)
No single metric tells the full story. See the OSTO:ORGC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OrganoClick AB is involved in the chemicals industry. Its product portfolio includes green chemical technologies for creating water repellency, biobased binders for increasing the mechanical strength, and wood treatment products for resistance to fungal degradation and resistance to fire. It operates in four business areas Functional Wood, Green coatings & maintenance products, Nonwoven & technical textile, and Other. The group has a single operating segment.
25GF Score
Get the complete analysis for OSTO:ORGC
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ORGC has been successfully added to your 
